Prolonged High-Fat Feeding Enhances Aortic 18F-FDG and 99mTc-Annexin A5 Uptake in Apolipoprotein E-Deficient and Wild-Type C57BL/6J Mice

18F-FDG, a marker of the enhanced metabolism characteristic of activated inflammatory cells, and 99mTc-annexin A5, a marker of apoptosis, are both widely believed to be useful for the imaging of unstable atheroma (rupture-prone vulnerable plaques [VP]). Serum cholesterol functions as a proinflammatory factor, driving the formation of VP, and affects the immune responses of aortic tissues systemically. It is therefore reasonable to postulate that prolonged cholesterol loading may alter the aortic uptake of these tracers. Here, we evaluated the aortic uptake of 18F-FDG and 99mTc-annexin A5 in apolipoprotein E-deficient (apoE−/−) and wild-type mice placed on high-fat diets. Methods: Male apoE−/− and wild-type (C57BL/6J) mice were maintained on high-fat diets after the age of 5 wk. Wild-type mice fed regular chow were used as controls. At the ages of 10, 18, and 25 wk (5–15 mice per group at each time point), mice were injected with 18F-FDG or 99mTc-annexin A5 after 12 h of fasting. At 1 h after 18F-FDG injection (or 2 h after 99mTc-annexin A5 injection), mice were sacrificed, and the aortas were removed for well-type scintillation counting of radioactivity. The results were expressed as percentage injected dose per gram of tissue and normalized by animal body weight [(ID%/g) × kg]. En face staining was then performed to assess the location and size (surface area) of the lipid pool within each aortic specimen. Concurrent blood samples were obtained to determine the plasma lipid profile of each group. Results: No atherosclerotic lesions were found in wild-type mice regardless of the diet, whereas the lesion area progressively increased with age in apoE−/− mice. Mean plasma cholesterol levels remained stable with the regular diet in wild-type mice (73–78 mg/dL) but increased with cholesterol feeding in wild-type mice (143–179 mg/dL) and in apoE−/− mice (>1,300 mg/dL). Aortic tracer uptake [(ID%/g) × kg] remained stable with the regular diet in wild-type mice (0.054–0.053 and 0.021–0.023 for 99mTc-annexin A5) but increased with cholesterol feeding in wild-type mice (0.164 for 18F-FDG and 0.036 for 99mTc-annexin A5 at 25 wk) and in apoE−/− mice (0.249 for 18F-FDG and 0.047 for 99mTc-annexin A5 at 25 wk). Conclusion: The accumulation of 18F-FDG and 99mTc-annexin A5 in aortic tissues is influenced not only by the progression of atherosclerotic disease but also by cholesterol loading over time.

[1]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[2]  C. Remacle,et al.  Triggering of inflammatory response by myeloperoxidase-oxidized LDL. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[3]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[4]  M. She,et al.  Minimally modified low-density lipoprotein induces monocyte chemotactic protein-1 expression in vivo and a novel model for monocyte adhesion to arterial intima. , 1999, Chinese medical journal.

[5]  P. Libby,et al.  Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. , 2004, The American journal of medicine.

[6]  Shuiqing Yu,et al.  Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice , 2005, Circulation research.

[7]  R. Virmani,et al.  Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque , 2003, Circulation.

[8]  M. Seldin,et al.  Control of Expression of Insulin Resistance and Hyperglycemia by Different Genetic Factors in Diabetic C57BL/6J Mice , 1991, Diabetes.

[9]  A. J. Valente,et al.  Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.

[10]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[11]  H. Tsutsui,et al.  Fatty acids increase the circulating levels of oxidative stress factors in mice with diet‐induced obesity via redox changes of albumin , 2007, The FEBS journal.

[12]  H. Strauss,et al.  Molecular imaging in nuclear cardiology. , 2004, Seminars in nuclear medicine.

[13]  P. Ridker,et al.  Increased inflammatory markers in children with familial hypercholesterolaemia , 2006, European journal of clinical investigation.

[14]  M. Feinglos,et al.  Diet-Induced Type II Diabetes in C57BL/6J Mice , 1988, Diabetes.

[15]  M. Davies,et al.  Atherosclerotic plaque caps are locally weakened when macrophages density is increased. , 1991, Atherosclerosis.

[16]  A. Freiman,et al.  Association of vascular 18F-FDG uptake with vascular calcification. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[18]  G. Chisolm,et al.  Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. , 2001, Trends in cardiovascular medicine.

[19]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[20]  Renu Virmani,et al.  Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. , 2003, Journal of interventional cardiology.

[21]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[22]  H. Watabe,et al.  (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  S. Ylä-Herttuala Oxidized LDL and atherogenesis. , 1999, Annals of the New York Academy of Sciences.

[24]  Yuan-Yuan Shi,et al.  Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  A. Hamsten,et al.  Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Breslow,et al.  The emergence of mouse models of atherosclerosis and their relevance to clinical research , 1997, Journal of internal medicine.

[27]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[28]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[29]  A. Nègre-Salvayre,et al.  Oxidized low-density lipoprotein-induced apoptosis. , 2002, Biochimica et biophysica acta.

[30]  C Bogardus,et al.  Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. , 2001, Obesity research.

[31]  P. Standley,et al.  Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. , 1994, American journal of hypertension.

[32]  Eran Leitersdorf,et al.  Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Nagara Tamaki,et al.  Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  D. Connolly,et al.  Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. , 1990, The Journal of biological chemistry.

[35]  D. Johns,et al.  Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension , 2001, Journal of hypertension.

[36]  C. Glass,et al.  Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  T. Fryer,et al.  Targeting the vulnerable plaque: The evolving role of nuclear imaging , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[38]  F. Blankenberg,et al.  Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  M. Daemen,et al.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. , 2004, The New England journal of medicine.

[40]  R. Virmani,et al.  Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.